Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252), a leading medical robotics company, has announced that it has received market approval from the National Medical Products Administration (NMPA) for its Toumai endoscopic surgery robot. This approval allows the robot to be used across multiple departments for a variety of surgical procedures.
Toumai Endoscopic Surgery Robot Features
The Toumai endoscopic surgery robot is designed to perform complex surgeries with minimally invasive techniques. It boasts an agile robotic arm that enhances the precision of operations, improves surgical safety, and reduces surgeon fatigue. Surgeons can operate comfortably from a console, viewing immersive 3D high-definition images of the surgical site while controlling the surgical instruments through the robotic arm.
Clinical Validation and Surgical Capabilities
Toumai offers a range of movements akin to the human wrist and filters out hand tremors, providing surgeons with greater control and precision. The robot has completed over 1,400 cases of robot-assisted clinical validation surgeries in more than 40 hospitals across 20 provinces. Its applications span various specialties, including urology, hepatobiliary surgery, gastrointestinal surgery, thoracic surgery, gynecology, and breast surgery.-Fineline Info & Tech
